Clinical Trial Update: Safety and Efficacy of SQIN™ on Xerosis in Adults With Mobility Problems and Paralysis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting safety and efficacy results for SQIN in treating xerosis in adults with mobility problems and paralysis, across Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerosis

Drugs mentioned

• SQIN

Snippet

Sponsor: Nordic Life Science Pipeline Inc. | Conditions: Xerosis | Phase 2, Phase 3 | Status: COMPLETED